186 related articles for article (PubMed ID: 36872368)
1. Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis.
Dong Y; Hu H; Zhang X; Zhang Y; Sun X; Wang H; Kan W; Tan MJ; Shi H; Zang Y; Li J
Signal Transduct Target Ther; 2023 Mar; 8(1):95. PubMed ID: 36872368
[TBL] [Abstract][Full Text] [Related]
2. PKA-dependent regulation of the histone lysine demethylase complex PHF2-ARID5B.
Baba A; Ohtake F; Okuno Y; Yokota K; Okada M; Imai Y; Ni M; Meyer CA; Igarashi K; Kanno J; Brown M; Kato S
Nat Cell Biol; 2011 Jun; 13(6):668-75. PubMed ID: 21532585
[TBL] [Abstract][Full Text] [Related]
3. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
[TBL] [Abstract][Full Text] [Related]
4. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
5. AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition.
Lin H; Li N; He H; Ying Y; Sunkara S; Luo L; Lv N; Huang D; Luo Z
Mol Pharmacol; 2015 Dec; 88(6):1062-71. PubMed ID: 26424816
[TBL] [Abstract][Full Text] [Related]
6. AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis.
Chou CC; Lee KH; Lai IL; Wang D; Mo X; Kulp SK; Shapiro CL; Chen CS
Cancer Res; 2014 Sep; 74(17):4783-95. PubMed ID: 24994714
[TBL] [Abstract][Full Text] [Related]
7. Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.
O'Brien AJ; Villani LA; Broadfield LA; Houde VP; Galic S; Blandino G; Kemp BE; Tsakiridis T; Muti P; Steinberg GR
Biochem J; 2015 Jul; 469(2):177-87. PubMed ID: 25940306
[TBL] [Abstract][Full Text] [Related]
8. Metformin attenuates albumin-induced alterations in renal tubular cells in vitro.
Allouch S; Munusamy S
J Cell Physiol; 2017 Dec; 232(12):3652-3663. PubMed ID: 28158902
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-Mesenchymal Transition Suppresses AMPK and Sensitizes Cancer Cells to Pyroptosis under Energy Stress.
Liang M; Li JW; Luo H; Lulu S; Calbay O; Shenoy A; Tan M; Law BK; Huang S; Xiao TS; Chen H; Wu L; Chang J; Lu J
Cells; 2022 Jul; 11(14):. PubMed ID: 35883651
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of megakaryocytic and erythroid differentiation by PHF2 histone demethylase.
Yang J; Ma J; Xiong Y; Wang Y; Jin K; Xia W; Chen Q; Huang J; Zhang J; Jiang N; Jiang S; Ma D
J Cell Physiol; 2018 Sep; 233(9):6841-6852. PubMed ID: 29336484
[TBL] [Abstract][Full Text] [Related]
11. Metformin attenuates the epithelial-mesenchymal transition of lens epithelial cells through the AMPK/TGF-β/Smad2/3 signalling pathway.
Wang L; Tian Y; Shang Z; Zhang B; Hua X; Yuan X
Exp Eye Res; 2021 Nov; 212():108763. PubMed ID: 34517004
[TBL] [Abstract][Full Text] [Related]
12. ARID5B promoted the histone demethylation of SORBS2 and hampered the metastasis of ovarian cancer.
Deng Y; Dong Y; Wu L; Zhang Q; Yang L
Pathol Res Pract; 2023 Dec; 252():154911. PubMed ID: 37948999
[TBL] [Abstract][Full Text] [Related]
13. Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis.
Zhao Z; Cheng X; Wang Y; Han R; Li L; Xiang T; He L; Long H; Zhu B; He Y
PLoS One; 2014; 9(4):e95884. PubMed ID: 24789104
[TBL] [Abstract][Full Text] [Related]
14. PHD finger protein 2 (PHF2) represses ribosomal RNA gene transcription by antagonizing PHF finger protein 8 (PHF8) and recruiting methyltransferase SUV39H1.
Shi G; Wu M; Fang L; Yu F; Cheng S; Li J; Du JX; Wong J
J Biol Chem; 2014 Oct; 289(43):29691-700. PubMed ID: 25204660
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation.
Groenendijk FH; Mellema WW; van der Burg E; Schut E; Hauptmann M; Horlings HM; Willems SM; van den Heuvel MM; Jonkers J; Smit EF; Bernards R
Int J Cancer; 2015 Mar; 136(6):1434-44. PubMed ID: 25080865
[TBL] [Abstract][Full Text] [Related]
16. Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells.
Qu C; Zhang W; Zheng G; Zhang Z; Yin J; He Z
Mol Cell Biochem; 2014 Jan; 386(1-2):63-71. PubMed ID: 24096736
[TBL] [Abstract][Full Text] [Related]
17. AMPKα2 translocates into the nucleus and interacts with hnRNP H: implications in metformin-mediated glucose uptake.
Kim N; Lee JO; Lee HJ; Lee SK; Moon JW; Kim SJ; Park SH; Kim HS
Cell Signal; 2014 Sep; 26(9):1800-6. PubMed ID: 24686086
[TBL] [Abstract][Full Text] [Related]
18. LKB1/AMPK inhibits TGF-β1 production and the TGF-β signaling pathway in breast cancer cells.
Li NS; Zou JR; Lin H; Ke R; He XL; Xiao L; Huang D; Luo L; Lv N; Luo Z
Tumour Biol; 2016 Jun; 37(6):8249-58. PubMed ID: 26718214
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells.
Xie Z; Dong Y; Scholz R; Neumann D; Zou MH
Circulation; 2008 Feb; 117(7):952-62. PubMed ID: 18250273
[TBL] [Abstract][Full Text] [Related]
20. Activation of AMP-activated Protein Kinase by Metformin Induces Protein Acetylation in Prostate and Ovarian Cancer Cells.
Galdieri L; Gatla H; Vancurova I; Vancura A
J Biol Chem; 2016 Nov; 291(48):25154-25166. PubMed ID: 27733682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
